Clinical trial · Observational

Prognostic Factors Affecting Survival of Gastric GIST

Clinicopathological Characteristics and Prognostic Factors of Gastrointestinal Stromal Tumors Located in the Stomach in Tunisian Patients

NCT04269941CI-TRIAL-00043435completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Gastrointestinal stromal tumor (GIST) is the most common non-epithelial mesenchymal tumor of the gastrointestinal tract. Surgical treatment is the only curative therapy for primary localized GIST. This study aimed to identify the clinicopathological characteristics of gastric GISTs and to study the predictive factors for recurrence in Tunisian patients.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Gastric GIST	Gastric Gastrointestinal Stromal Tumor	ALIAS	0.90

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
total or subtotal gastrectomy	Other	—	UNRESOLVED

Design

Arms and outcomes

Arms (1)

label
prognostic factors of gastrointestinal stromal tumors
description
for the patient diagnosed with gastic GIST , they underwent subtotal or total gastrectomy.
interventionNames
1. Other: total or subtotal gastrectomy

Primary outcomes (1)

measure
number of patients operated for gastric GIST
timeFrame
30 days
description
the patient having adenocarcinoma or other histopathological type are excluded

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 10 Years
Maximum age: 90 Years

Show eligibility criteria text

Inclusion Criteria: patient having gastric GIST

\-

Exclusion Criteria:

* patient operated for other gastric tumors

References

Publications (0)

Data not yet available

No reference posted for this study.